In this commentary from Clinical Care Options (CCO), Alexander Drilon, MD, discusses best practices in the use of TRK inhibitor therapy
Downloadable slideset reviewing the latest data informing optimal use of immune checkpoint inhibition for the treatment of pretreated SCLC, from Clinical Care Options (CCO)
In this slideset from Clinical Care Options, Jamie E. Chaft, MD outlines the current approach for the use of IO biomarkers and immunotherapy approaches for lung cancer.
Downloadable slideset reviewing the latest data informing optimal use of immune checkpoint inhibition for the treatment of SCLC, from Clinical Care Options (CCO)
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.